KARA HYMAN: Open Payments
NPI 1023328408 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 11 payments from 8 companies in 2025. Trend: 2023 $444 · 2024 $582 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 2 | $93 |
| IBSA Pharma Inc. | 3 | $70 |
| Ardelyx, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: Tirosint, IBSRELA, NURTEC ODT, QULIPTA, XIFAXAN, Quviviq, JARDIANCE.
Industry payments across FL — which companies pay providers there.
